
Steroid vs. Anti-VEGF Injections for Diabetic Macular Edema
Understanding the Two Main Types of Injections for DME
Both anti-VEGF and steroid injections are delivered directly into the eye through a procedure called an intravitreal injection. While both aim to reduce fluid in the macula and protect vision, they work through different mechanisms and are suited to different patient situations.
Anti-VEGF injections target a protein called vascular endothelial growth factor (VEGF), which in DME causes retinal blood vessels to become leaky, allowing fluid and protein to seep into surrounding tissue and cause swelling. These medications bind to VEGF and block its effects, helping the blood vessels tighten up and the macula dry out. Over time, this can improve visual clarity and reduce distortion.
Anti-VEGF therapy is the most widely used first-line treatment for DME. Multiple injections are typically needed, especially during the first year, because the effect of each injection wears off as VEGF levels rise again between treatments. The procedure itself takes only a few minutes during a brief office visit.
Steroid treatments reduce inflammation inside the eye, which is a key driver of blood vessel leakage and tissue damage in DME. Corticosteroids suppress this inflammatory response, stabilize the blood-retinal barrier (the protective layer controlling what passes from the bloodstream into the retina), and also reduce VEGF production, addressing the problem from multiple angles.
Steroid treatments come in several forms, from single injections that provide short-term relief to sustained-release implants that slowly deliver medication over a longer period. Dexamethasone implants typically release medication for approximately three to four months. Fluocinolone acetonide implants can release medication for up to three years, requiring far fewer office visits for retreatment.
Both anti-VEGF and steroid treatments are delivered through a small needle into the vitreous (the gel-filled interior of the eye) and require ongoing monitoring by your doctor to assess how well the treatment is working. Neither approach is a permanent cure, and most patients need continued treatment to keep the macular swelling under control and protect their vision over time.
When Your Doctor Might Recommend Each Option
Choosing between anti-VEGF and steroid treatment is a personalized decision based on your eye health, medical history, lifestyle, and how your eye responds to treatment. Your doctor will weigh all of these factors carefully before making a recommendation.
For most patients with DME, anti-VEGF injections are the first treatment recommended. Large clinical studies have shown that anti-VEGF therapy improves vision in a significant number of patients and stabilizes vision in many more, with a favorable safety profile. Anti-VEGF medications do not cause cataracts or raise eye pressure, which are important advantages over steroids.
Your doctor will typically start with anti-VEGF therapy and monitor your response over several months. Injections may be given monthly at first to bring swelling under control, then gradually spaced further apart as the macula responds, using a strategy often called 'treat and extend.' The goal is to find the longest interval between injections that still keeps swelling controlled and vision stable.
Steroid implants are typically considered when anti-VEGF injections have not adequately controlled macular edema after a reasonable course of treatment, sometimes referred to as anti-VEGF-resistant or refractory DME. If fluid in the macula has not improved enough, or keeps returning quickly between injections, your doctor may recommend switching to or adding a steroid implant.
Steroids may also be preferred for patients who have difficulty keeping up with the frequent visit schedule that anti-VEGF therapy requires. Because steroid implants last longer, they require fewer office visits each year. For patients who have already had cataract surgery (meaning they have an artificial lens), the main steroid side effect of cataract progression is no longer a concern, making steroid implants a particularly practical option for this group.
Your doctor takes several factors into account when recommending a treatment, including the severity and duration of your macular edema, whether you have had cataract surgery, your ability to attend regular injection appointments, your response to any previous treatments, and any other eye conditions you may have.
- History of elevated eye pressure or glaucoma may call for extra caution with steroids
- Already having had cataract surgery removes a major steroid-related risk
- Difficulty attending frequent visits may make a longer-lasting steroid implant more suitable
- Strong inflammatory component to the edema may respond better to steroids
Your doctor will walk you through the expected benefits, potential side effects, and practical considerations of each option so that you can make a well-informed decision together.
Comparing Side Effects and Risks
Both treatment categories carry some risk, and understanding those risks helps you and your doctor choose the approach that best fits your overall health picture. Neither option is risk-free, and both require ongoing monitoring.
Anti-VEGF injections are generally well tolerated. The most common side effects are related to the injection procedure itself and are usually mild and temporary.
- Temporary redness or mild eye irritation
- A feeling of pressure in the eye right after the injection
- Small floating spots from tiny air bubbles, which resolve quickly
The risk of serious complications such as infection inside the eye (endophthalmitis), retinal detachment, or significant bleeding is very low with each injection. Anti-VEGF medications do not cause cataracts or raise eye pressure, which distinguishes them from steroid treatments. Your doctor will discuss any specific concerns based on your overall health.
The two most significant side effects of intravitreal steroids are cataract progression and elevated intraocular pressure (the pressure inside the eye). Corticosteroids accelerate clouding of the natural lens, meaning patients who still have their natural lens are likely to develop cataracts sooner than they otherwise would, often eventually requiring cataract surgery. For patients who have already had cataract surgery, this side effect is not a concern.
Elevated eye pressure is another important risk to monitor. Corticosteroids can cause pressure inside the eye to rise, which can damage the optic nerve if uncontrolled. Most cases of steroid-induced pressure elevation can be managed with eye drops, but in some cases additional steps may be needed. Your doctor will monitor your eye pressure closely after placing a steroid implant and will weigh these risks against the potential benefits before recommending this approach.
Anti-VEGF injections carry a lower risk of cataracts and elevated eye pressure, while steroid implants carry a higher risk of both but offer the advantages of longer duration and fewer required office visits. The choice is not about avoiding all risk but about managing risk wisely based on your individual situation.
A patient who has already had cataract surgery and has difficulty attending monthly appointments may find the risk of elevated eye pressure from steroids acceptable in exchange for the convenience of a longer-lasting implant. A patient with a history of glaucoma may prefer the safety profile of anti-VEGF therapy even if it means more frequent visits. Your doctor can help you weigh these tradeoffs in the context of your overall eye health.
Switching Treatments and Combination Approaches
DME management is not a one-size-fits-all process. When one treatment approach is not providing enough benefit, your doctor may recommend switching or combining treatments to better control the swelling and protect your vision.
If your macular edema does not respond adequately to anti-VEGF injections after several months of consistent treatment, your doctor may recommend switching to a steroid implant. This is a common clinical decision and does not mean your initial treatment failed. Different patients respond differently to each class of medication, and some eyes have a stronger inflammatory component that responds better to the anti-inflammatory action of steroids.
The switch typically involves placing a steroid implant during a brief office procedure, similar to the anti-VEGF injection appointments you are already familiar with. Your doctor will monitor your response over the following weeks using optical coherence tomography (OCT), a painless imaging test that measures the layers of the retina, along with visual acuity testing.
In some cases of stubborn DME, your doctor may recommend using anti-VEGF injections and a steroid implant together. Because the two treatments work through different mechanisms, combining them may provide better control of swelling than either alone. Anti-VEGF blocks the VEGF protein that drives leakage, while steroids address the underlying inflammation that also contributes to fluid buildup.
Combination therapy is typically reserved for cases that have not responded well to either treatment on its own. If your doctor recommends this approach, they will explain the rationale, the treatment schedule, and how your response will be monitored closely over time.
Changing from one treatment to another, or adding a second treatment, can feel uncertain. It is natural to wonder whether the new approach will work and what side effects to watch for. Keep in mind that your doctor is making this recommendation based on how your eye has responded, and the change is intended to improve your outcome.
After any change in treatment, your doctor will schedule follow-up visits to check your progress with an OCT scan and visual acuity test. If you notice any new symptoms such as increased eye pain, a sudden change in vision, or new floaters, contact your doctor promptly rather than waiting for your next scheduled visit.
Living With Ongoing Treatment for DME
Treatment for diabetic macular edema is typically a long-term commitment. Staying consistent with your appointments and monitoring your vision between visits are both important parts of protecting your central vision.
Whether you are receiving anti-VEGF injections or steroid implants, keeping up with your treatment schedule is essential. Missing or delaying appointments can allow macular edema to worsen and may result in vision loss that is difficult to recover. Treating your injection appointments as non-negotiable commitments protects the progress your eyes have already made.
Practical strategies can help you stay on track. Setting phone reminders, keeping a dedicated calendar, or arranging transportation in advance can reduce barriers to attendance. Some practices offer scheduling assistance or can batch appointments to minimize the number of separate trips needed.
Between office visits, you can check your own vision for signs that the macular edema may be returning. A simple method is to cover one eye at a time and look at a straight line, such as a door frame, to see if it appears wavy, bent, or distorted. Your doctor may also provide you with an Amsler grid, a printed grid of straight lines with a dot in the center, specifically for this purpose.
If you notice new distortion, increased blurriness, or any sudden change in vision, contact your doctor promptly rather than waiting for your next scheduled visit. Managing your blood sugar and blood pressure consistently also supports the work that injections are doing to dry out the macula, as these factors directly influence how well DME responds to treatment.
Having ongoing conversations with your doctor about what matters most to you helps ensure your care fits your life. Some patients prioritize maximizing visual acuity, while others want to reduce office visit frequency or minimize side effects. Your doctor needs to understand your priorities in order to tailor the treatment approach accordingly.
Ask your doctor what your OCT scan shows at each visit, whether any adjustments to your plan are being considered, and what to expect next. If the appointment schedule feels unmanageable or if you are experiencing side effects that concern you, speak up. Open communication helps your doctor find the approach that best protects your vision while fitting your individual circumstances.
Frequently Asked Questions
The following questions address common points of uncertainty that patients often raise when comparing treatment options for diabetic macular edema.
Yes, it can meaningfully shift the risk-benefit balance. Cataract formation is one of the most significant side effects of steroid implants, but if you have already had cataract surgery and have an artificial lens in place, this risk no longer applies to you. This makes steroid implants a more attractive option for patients who are pseudophakic (have an artificial lens), particularly if they also have difficulty attending frequent anti-VEGF injection appointments. Your doctor will still monitor your eye pressure closely if a steroid implant is chosen.
Your doctor uses OCT imaging to measure the thickness of your macula at each visit, along with visual acuity testing. If your macula remains thickened or your vision has not improved adequately after a consistent course of anti-VEGF injections, typically several months of monthly or near-monthly treatment, your doctor will discuss whether switching to a steroid implant is appropriate. The decision also takes into account how quickly the fluid returns between injections and whether any improvement has plateaued.
In most cases, steroid-induced elevated eye pressure can be managed effectively with prescription eye drops that lower pressure. For the majority of patients, this side effect is controllable with medication and does not result in lasting eye damage when monitored regularly. However, patients with pre-existing glaucoma or a strong history of steroid-related pressure increases are at higher risk and require extra caution. Your doctor will review your history carefully before recommending a steroid implant and will monitor your pressure at follow-up visits.
Not necessarily. Because steroid implants are long-acting, they do not need to be replaced at the same frequency as anti-VEGF injections. In a combination approach, you may still receive anti-VEGF injections on a regular schedule while a steroid implant works in the background for several months at a time. The total number of procedures depends on which specific medications are being used and how your eye is responding. Your doctor will plan the schedule to minimize the treatment burden while still keeping the swelling controlled.
The duration varies by medication. The effect of an individual anti-VEGF injection typically wears off within four to eight weeks, though some patients can extend the interval between injections as their condition stabilizes. Dexamethasone steroid implants generally provide benefit for approximately three to four months. Fluocinolone acetonide implants can release medication for up to three years, making them the longest-lasting available option. Your doctor will select the duration that best balances treatment effectiveness with your risk profile and practical needs.
Do not wait for your next scheduled visit. New or worsening distortion, a sudden increase in blurriness, new floaters, or any other unexpected change in vision should prompt you to contact your doctor's office promptly. Some changes can indicate that the macular edema is returning or that a complication has developed, and early evaluation allows for faster intervention. Your care team would always rather hear from you sooner than later when it comes to changes in vision.
Expert Retina Care Close to Home
At Retina Associates of Greater Philadelphia, our team of experienced doctors is dedicated to helping patients with diabetic macular edema get the right treatment for their individual needs. We offer personalized, evidence-based care across our five convenient locations throughout the greater Philadelphia region, so expert retina care is never far away. We welcome you to schedule a visit and let us help you protect your vision with a treatment plan built around you.
